After the recent  successful chemical synthesis of a natural compound that has shown efficacy as a potential chemotherapy for the treatment of liver cancer, Q BioMed and Chemveda Life Sciences have formalized a collaboration to continue the work and to scale-up manufacturing of cGMP product for planned pre-clinical testing and clinical trials.   Since February 2017, Q BioMed and Chemveda have been engaged in a joint research program to synthesize uttroside B and several other derivatives. The go...